EuroSCORE II Explained: How European Heart Surgery Risk Scoring Works

A Brief History of EuroSCORE

Before the late 1990s, cardiac surgeons estimated surgical risk largely through clinical judgment and experience. The European System for Cardiac Operative Risk Evaluation — EuroSCORE — changed that by introducing a standardized, data-driven approach to predicting mortality after heart surgery.

The Original EuroSCORE (1999)

The first EuroSCORE was published in 1999, derived from a database of 19,030 patients who underwent cardiac surgery at 128 centers across eight European countries. It used an additive scoring system: each risk factor carried a fixed number of points, and the points were summed to produce a predicted mortality percentage. Simple, fast, and easy to calculate at the bedside.

Logistic EuroSCORE

Surgeons quickly recognized that the additive model underestimated risk in high-risk patients. The logistic EuroSCORE applied the same variables but used a logistic regression equation, producing more accurate predictions at the extremes of risk. However, it was harder to calculate without a computer.

EuroSCORE II (2012)

By 2012, cardiac surgery had evolved substantially — new techniques, better anesthesia, improved postoperative care. The original EuroSCORE, calibrated on 1990s data, was significantly overestimating mortality in contemporary practice. EuroSCORE II was developed from a new dataset of 22,381 patients operated on in 2010, with updated variables and recalibrated coefficients.

EuroSCORE II is the current standard in European cardiac surgery and is widely used alongside the STS score globally. You can estimate your surgical risk with our risk calculator, which incorporates both scoring systems.

The 18 Variables in EuroSCORE II

EuroSCORE II uses 18 variables organized into three categories:

Patient-Related Factors

• Age — Continuous variable (not grouped); risk increases progressively
• Sex — Female sex carries additional risk for certain procedures
• Renal impairment — Classified by creatinine clearance: normal, moderate (50–85 mL/min), severe (<50 mL/min), or dialysis
• Extracardiac arteriopathy — Peripheral vascular disease, carotid disease, or abdominal aortic disease
• Poor mobility — Severe impairment of mobility from musculoskeletal or neurological dysfunction
• Previous cardiac surgery — Any prior operation requiring opening of the pericardium
• Chronic lung disease — Long-term use of bronchodilators or steroids for lung disease
• Active endocarditis — Patient still on antibiotic treatment for endocarditis at the time of surgery
• Critical preoperative state — Ventricular tachycardia/fibrillation, aborted sudden death, preoperative cardiac massage, ventilation, inotropic support, IABP, or preoperative acute renal failure
• Diabetes on insulin — Insulin-dependent diabetes mellitus

Cardiac-Related Factors

• NYHA class — New York Heart Association functional classification (I through IV)
• CCS class IV angina — Angina at rest (Canadian Cardiovascular Society class IV)
• LV function — Ejection fraction classified as good (>50%), moderate (31–50%), poor (21–30%), or very poor (≤20%)
• Recent MI — Myocardial infarction within 90 days
• Pulmonary hypertension — Systolic PA pressure: moderate (31–55 mmHg) or severe (>55 mmHg)

Operation-Related Factors

• Urgency — Elective, urgent, emergency, or salvage
• Weight of the intervention — Isolated CABG, single non-CABG, two procedures, or three or more procedures
• Surgery on thoracic aorta — Any procedure involving the thoracic aorta

Each variable enters a logistic regression equation with specific coefficients. The output is a predicted probability of in-hospital mortality. Calculate your own estimated risk with our risk calculator.

EuroSCORE II vs. STS Score: Key Differences

Both EuroSCORE II and the STS score aim to predict cardiac surgical mortality, but they differ in important ways:

Data Source

• EuroSCORE II — Derived from European surgical data (128 centers, 43 countries in the original; 22,381 patients in the 2010 update)
• STS score — Derived from the STS National Database, which includes data from the vast majority of cardiac surgery programs in the United States (millions of cases)

This distinction matters because patient populations, surgical techniques, and healthcare systems differ between Europe and the United States. A risk model calibrated on European patients may not perfectly predict outcomes in American patients, and vice versa.

Variables

• EuroSCORE II uses 18 variables — fewer, broader categories
• STS score uses approximately 40+ variables — more granular clinical detail

The STS model captures more nuance. For example, it distinguishes between different types of diabetes management (diet, oral agents, insulin), grades chronic lung disease severity (mild, moderate, severe), and includes specific procedure-related variables that EuroSCORE groups together.

Calibration and Updates

• EuroSCORE II — Based on 2010 data; not continuously updated
• STS score — Updated regularly with contemporary data from the STS National Database

The STS model benefits from a continuous data pipeline that keeps it calibrated to current practice. EuroSCORE II, while still widely used, is based on data that is now over 15 years old.

Procedure Specificity

• EuroSCORE II — A single model for all cardiac surgery
• STS score — Separate models for isolated CABG, isolated valve replacement, and combined CABG + valve procedures

Procedure-specific models are generally more accurate because the risk factors that matter most differ between operations.

Strengths of EuroSCORE II

Despite its limitations relative to STS, EuroSCORE II has genuine strengths:

• Simplicity — Fewer variables make it faster to calculate and easier to use in busy clinical environments
• Global applicability — Validated across diverse international populations
• TAVR decision-making — EuroSCORE has historically been used in European TAVR guidelines as a risk stratification tool, and many TAVR trials used EuroSCORE for patient enrollment criteria
• Widely available — Free online calculators make it accessible to any clinician worldwide
• Comprehensive scope — Covers all cardiac surgery types in a single model, useful when comparing risk across different procedures

Known Limitations

EuroSCORE II has well-documented limitations that clinicians and patients should understand:

Overestimation in Low-Risk Patients

This is the most consistently reported issue. Multiple validation studies have shown that EuroSCORE II overestimates mortality in low-risk patients — sometimes by a factor of two or more. A patient with a predicted mortality of 2% may actually face a risk closer to 0.8–1.0% at an experienced center.

This overestimation has practical consequences. In the context of TAVR vs. SAVR decisions, an inflated EuroSCORE might inappropriately push a low-risk patient toward TAVR when surgery would offer better long-term valve durability.

Underestimation in High-Risk Patients

Conversely, some studies have found that EuroSCORE II underestimates risk in certain high-risk subgroups — particularly patients with multiple comorbidities or those undergoing complex multi-valve procedures.

Missing Variables

Like the STS score, EuroSCORE II does not directly capture:

• Frailty — An increasingly recognized predictor of surgical outcomes
• Liver disease severity — Cirrhosis dramatically increases surgical risk
• Nutritional status — Malnutrition and sarcopenia affect healing and recovery
• Cognitive function — Dementia and cognitive impairment predict poor postoperative outcomes
• Surgeon and institutional volume — Perhaps the most important predictor of all

Practical Use in Heart Team Conferences

In practice, most Heart Teams calculate both EuroSCORE II and STS score for every patient. The two scores are compared and discussed alongside the clinical picture that no model fully captures.

When the scores agree, the team has greater confidence in the risk estimate. When they diverge — particularly when EuroSCORE II is significantly higher than STS — the team investigates why. Often, the discrepancy reflects EuroSCORE II's known overestimation pattern, and the STS score is given more weight in the final decision.

Both scores serve as a foundation for discussion, not a replacement for clinical judgment. A patient with a low numerical score but significant frailty, poor nutritional status, or limited social support may carry higher real-world risk than either model predicts. Conversely, a fit, active patient with a moderately elevated score may do better than predicted.

Which Score Should You Ask About?

As a patient, you should ask your Heart Team for both your STS score and your EuroSCORE II. Having both numbers gives you:

• A range of estimated risk rather than a single point estimate
• Insight into how different models weight your specific risk factors
• A basis for informed questions about your treatment options
• Data to bring to a second opinion consultation

You can calculate your estimated scores using our risk calculator, which provides both STS and EuroSCORE II estimates in a patient-friendly format.

Take Control of Your Risk Assessment

Understanding your EuroSCORE II — and how it compares to your STS score — puts you in a stronger position to participate in decisions about your cardiac care. Use our risk calculator to explore your numbers, and if you want an independent Heart Team to review your case and explain what your risk scores mean for your specific situation, request a second opinion from WhiteGloveMD. Visit our pricing page to learn more about our transparent, straightforward fee structure.